Active Ingredient(s): Flucytosine
FDA Approved: * November 26, 1971
Pharm Company: * VALEANT
Category: Antifungal

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Ancobon Overview

Flucytosine, also known as 5-fluorocytosine (5-FC), is an antifungal medication.[1] It is specifically used, together with amphotericin B, for serious Candida infections and cryptococcosis.[1] It may be used by itself or with other antifungals for chromomycosis.[1] Flucytosine is used by mouth and by injection into a vein.[1][2] Common side effects include bone marrow suppression, loss of appetite, diarrhea, vomit...

Read more Ancobon Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Ancobon Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Capsule: 250mg, 500mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Ancobon: (3 results)

Sorted by National Drug Code
  • 0187-3554 Ancobon 250 mg Oral Capsule by Valeant Pharmaceuticals North America LLC
  • 0187-3555 Ancobon 500 mg Oral Capsule by Valeant Pharmaceuticals North America LLC
  • 55154-6575 Ancobon 500 mg Oral Capsule by Cardinal Health

Other drugs which contain Flucytosine or a similar ingredient: (1 result)